Revenue
2022
2023
2024
2025
Guardian Pharmacy Services, Inc. (GRDN)
Price$43.39Cached quote
Net income
2022
2023
2024
2025
Free cash flow
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $1.45B | $1.23B | $1.05B | $908.9M |
| Gross profit | $292.7M | $244.4M | $208.3M | $185.9M |
| Gross margin | 20.21% | 19.89% | 19.91% | 20.45% |
| Operating expenses | $220.0M | $307.3M | $167.4M | $133.9M |
| Operating income | $72.7M | −$62.9M | $40.9M | $52.0M |
| Operating margin | 5.02% | −5.12% | 3.91% | 5.72% |
| EBITDA | $95.0M | −$43.1M | $58.8M | $68.2M |
| EBITDA margin | 6.56% | −3.51% | 5.62% | 7.50% |
| Net income | $49.2M | −$110.0M | $23.9M | $35.4M |
| Net profit margin | 3.40% | −8.96% | 2.28% | 3.90% |
| Basic EPSper basic share | $0.79 | -$1.77 | $0.00 | $0.58 |
| Diluted EPSper diluted share | $0.78 | -$1.77 | $0.00 | $0.58 |
Owners
Reported shareholders
≈21.30%of listed shares
Salentine Thomas J Jr10.61M shares · Mar 28, 2026
View holders
| Holder | % owned |
|---|---|
Salentine Thomas J Jr | ≈21.30%10.61M shares |
BINDLEY WILLIAM E | ≈21.23%10.57M shares |
Bindley Capital Partners I, LLC | ≈21.23%10.57M shares |
Ackerman John | ≈6.56%3.27M shares |
FMR LLC | 6.51%3.24M shares |
Pharmacy Investors, LLC | ≈4.92%2.45M shares |
Burke Fred | ≈4.30%2.14M shares |
WELLINGTON MANAGEMENT GROUP LLP | 3.47%1.73M shares |
BlackRock, Inc. | 3.17%1.58M shares |
VANGUARD CAPITAL MANAGEMENT LLC | 2.77%1.38M shares |
Woodline Partners LP | 2.62%1.31M shares |
Valiant Capital Management, L.P. | 2.38%1.19M shares |
T. Rowe Price Investment Management, Inc. | 2.24%1.12M shares |
Forbes Kendall | ≈2.13%1.06M shares |
Boston Partners | 1.98%983.87K shares |
FRANKLIN RESOURCES INC | 1.94%966.21K shares |
TimesSquare Capital Management, LLC | 1.91%951.64K shares |
Morris David K | ≈1.80%896.34K shares |
LOOMIS SAYLES & CO L P | 1.75%869.84K shares |
Cardinal Equity Fund, L.P. | ≈1.64%816.18K shares |
Percentages use 49.79M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Reported positions exceed 100% in total, so the circle shows the selected holder only.
Source: SEC Form 4 ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Mar 20, 2026Form 4 | Morris David KSee Remarks | SellClass A Common Stock | 187.9K | $29.68 | $5.58M | 254.5K |
| Mar 20, 2026Form 4 | Pharmacy Investors, LLCOther | SellClass A Common Stock | 827.6K | $29.68 | $24.56M | 1.04M |
| Mar 20, 2026Form 4 | Burke FredSee Remarks | SellClass A Common Stock | 671.4K | $29.68 | $19.93M | 840.4K |
| Mar 20, 2026Form 4 | Salentine Thomas J JrDirector,TenPercentOwner | SellClass A Common Stock · indirect | 3.57M | $29.68 | $105.98M | 4.47M |
| Mar 20, 2026Form 4 | Bindley Capital Partners I, LLCTenPercentOwner | SellClass A Common Stock | 3.57M | $29.68 | $105.98M | 4.47M |